- NEXI Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
NexImmune (NEXI) 8-K15 Aug 22NexImmune Reports Second Quarter 2022 Financial Results and Highlights FDA Clearance of IND for NEXI-003 for the Treatment of HPV-Related CancersFinancial data
Company Profile